|
Real-time Estimate
Cboe BZX
14:42:17 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 72.25 USD | -0.54% |
|
+2.05% | -4.82% |
| 03:28am | PTC Therapeutics, Inc. - Special Call | |
| 07-30 | PTC Therapeutics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
Company Valuation: PTC Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,816 | 2,786 | 2,080 | 3,481 | 6,099 | 6,063 | - | - |
| Change | - | -1.06% | -25.35% | 67.4% | 75.18% | -0.59% | - | - |
| Enterprise Value (EV) 1 | 2,474 | 2,947 | 1,487 | 2,627 | 4,440 | 4,191 | 3,917 | 4,192 |
| Change | - | 19.12% | -49.54% | 76.65% | 69% | -5.6% | -6.54% | 7.01% |
| P/E | -5.36x | -4.9x | -3.29x | -9.54x | 9.76x | 42.1x | 31.7x | 19.1x |
| PBR | 1,952x | -7.89x | -2.55x | -3.19x | -30.1x | -53.8x | 35.7x | 9.66x |
| PEG | - | -1.01x | -0.44x | 0.2x | -0x | -0.5x | 1x | 0.3x |
| Capitalization / Revenue | 5.23x | 3.99x | 2.22x | 4.32x | 3.52x | 4.83x | 4.43x | 3.8x |
| EV / Revenue | 4.59x | 4.22x | 1.59x | 3.26x | 2.57x | 3.34x | 2.86x | 2.62x |
| EV / EBITDA | -7.97x | -9.25x | -7.33x | -11.6x | 4.9x | 10.2x | 7.19x | 6.08x |
| EV / EBIT | -6.61x | -6.59x | -3.38x | -8.68x | 5.12x | 11.4x | 8.68x | 6.86x |
| EV / FCF | -8.85x | -7.58x | -7.96x | -23x | 6.32x | -322x | 63.2x | 17.5x |
| FCF Yield | -11.3% | -13.2% | -12.6% | -4.35% | 15.8% | -0.31% | 1.58% | 5.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.43 | -7.79 | -8.37 | -4.73 | 7.78 | 1.726 | 2.294 | 3.811 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 538.6 | 698.8 | 937.8 | 806.8 | 1,731 | 1,255 | 1,370 | 1,597 |
| EBITDA 1 | -310.3 | -318.6 | -202.9 | -226.9 | 905.8 | 411.6 | 544.5 | 689.3 |
| EBIT 1 | -374.4 | -447.4 | -439.5 | -302.6 | 866.9 | 366.4 | 451.1 | 610.8 |
| Net income 1 | -523.9 | -559 | -626.6 | -363.3 | 682.6 | 163.4 | 215.6 | 345.1 |
| Net Debt 1 | -341.9 | 161 | -592.5 | -854.3 | -1,659 | -1,871 | -2,145 | -1,871 |
| Reference price 2 | 39.83 | 38.17 | 27.56 | 45.14 | 75.96 | 72.64 | 72.64 | 72.64 |
| Nbr of stocks (in thousands) | 70,698 | 72,991 | 75,463 | 77,125 | 80,288 | 83,461 | - | - |
| Announcement Date | 2/22/22 | 2/21/23 | 2/29/24 | 2/27/25 | 2/19/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 41.82x | 4.78x | 14.66x | -.--% | 6.06B | |
| 34.6x | 12.64x | 25.73x | 0.57% | 1,088B | |
| 29.02x | - | - | 2.06% | 629B | |
| 31.76x | 7.4x | 15.37x | 2.76% | 440B | |
| 20.37x | 4.83x | 11.97x | 2.73% | 359B | |
| 21.72x | 5.63x | 14.03x | 2.85% | 291B | |
| 20.24x | 4.18x | 11.87x | 2.1% | 245B | |
| 26.11x | 6.86x | 12.2x | 2.42% | 225B | |
| 13.56x | 4.86x | 10.12x | 3.76% | 204B | |
| -42.19x | 6.04x | 34.06x | 2.43% | 168B | |
| Average | 19.70x | 6.36x | 16.67x | 2.17% | 365.53B | |
| Weighted average by Cap. | 24.69x | 8.25x | 18.72x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PTCT Stock
- Valuation PTC Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
